AmoyDx and PREMIA Announce the Commercial Launch of the AmoyDx® Pan Lung Cancer PCR Panel in Japan

Xiamen and Hong Kong, January 13, 2022 -- Amoy Diagnostics Co., Ltd., (“AmoyDx”) and

PREMIA Holdings (HK) Limited (“PREMIA”) today announced the commercial launch of the

AmoyDx® Pan Lung Cancer PCR Panel (the “PLC Panel”) in Japan as a reimbursed companion diagnostic for multiple anti-cancer agents. AmoyDx is the inventor and manufacturer and PREMIA the developer of the PLC Panel in Japan.


Read full press release below



1-13-22 AmoyDx® Pan Lung Cancer PCR Panel
.pdf
Download PDF • 248KB